Abstract:Background and objectives: Non-alcoholic fatty liver disease (NAFLD) is a common liver disease with a rapidly growing incidence worldwide. For prognostication and therapeutic decisions, it is important to distinguish the pathological stages of NAFLD: steatosis, steatohepatitis, and liver fibrosis, which are definitively diagnosed on invasive biopsy. Non-invasive ultrasound (US) imaging, including US elastography technique, and clinical parameters can be used to diagnose and grade NAFLD and its complications. Artificial intelligence (AI) is increasingly being harnessed for developing NAFLD diagnostic models based on clinical, biomarker, or imaging data. In this work, we systemically reviewed the literature for AI-enabled NAFLD diagnostic models based on US (including elastography) and clinical (including serological) data. Methods: We performed a comprehensive search on Google Scholar, Scopus, and PubMed search engines for articles published between January 2005 and June 2023 related to AI models for NAFLD diagnosis based on US and/or clinical parameters using the following search terms: "non-alcoholic fatty liver disease", "non-alcoholic steatohepatitis", "deep learning", "machine learning", "artificial intelligence", "ultrasound imaging", "sonography", "clinical information". Results: We reviewed 64 published models that used either US (including elastography) or clinical data input to detect the presence of NAFLD, non-alcoholic steatohepatitis, and/or fibrosis, and in some cases, the severity of steatosis, inflammation, and/or fibrosis as well. The performances of the published models were summarized, and stratified by data input and algorithms used, which could be broadly divided into machine and deep learning approaches. Conclusion: AI models based on US imaging and clinical data can reliably detect NAFLD and its complications, thereby reducing diagnostic costs and the need for invasive liver biopsy. The models offer advantages of efficiency, accuracy, and accessibility, and serve as virtual assistants for specialists to accelerate disease diagnosis and reduce treatment costs for patients and healthcare systems.

Intelligent Diagnosis of Non-alcoholic Fatty Liver Disease Based on Multi-modal Ultrasound Features

[Research Advances in Diagnosis of Non-Alcoholic Fatty Liver Disease].

Ultrasound‐Based Machine Learning Approach for Detection of Nonalcoholic Fatty Liver Disease

The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease

Intelligent Grading of Liver Fibrosis, Inflammation and Steatosis Using Handcrafted and Deep Features From Multimodal Ultrasound Data

Deep Learning With Ultrasound Images Enhance the Diagnosis of Nonalcoholic Fatty Liver

New horizon of ultrasound for screening and surveillance of non-alcoholic fatty liver disease spectrum

Simultaneous grading diagnosis of liver fibrosis, inflammation, and steatosis using multimodal quantitative ultrasound and artificial intelligence framework

Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications

Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease

A novel quantitative ultrasound technique for identifying non‐alcoholic steatohepatitis

Application of artificial intelligence techniques for non-alcoholic fatty liver disease diagnosis: A systematic review (2005-2023)

Application of Quantitative Ultrasonography and Artificial Intelligence for Assessing Severity of Fatty Liver: A Pilot Study

Machine learning model for non-alcoholic steatohepatitis diagnosis based on ultrasound radiomics

Role of Imaging Techniques in Clinical Research and Practice on Nonalcoholic Fatty Liver Disease

Characterization of signature trends across the spectrum of non-alcoholic fatty liver disease using deep learning method

Performance of Imaging Techniques in Non-invasive Diagnosis of Non-alcoholic Fatty Liver Disease in Children: A Systematic Review and Meta-Analysis

Technical Acoustic Measurements Combined with Clinical Parameters for the Differential Diagnosis of Nonalcoholic Steatohepatitis

Application of Deep Learning in Quantitative Analysis of 2‐Dimensional Ultrasound Imaging of Nonalcoholic Fatty Liver Disease

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future

Multi-modal Learning based Prediction for Disease